Medpace Holdings EBITDA 2014-2025 | MEDP

Medpace Holdings annual and quarterly EBITDA history from 2014 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Medpace Holdings EBITDA for the quarter ending March 31, 2025 was $0.120B, a 8.46% increase year-over-year.
  • Medpace Holdings EBITDA for the twelve months ending March 31, 2025 was $0.486B, a 27.08% increase year-over-year.
  • Medpace Holdings 2024 annual EBITDA was $0.476B, a 31.11% increase from 2023.
  • Medpace Holdings 2023 annual EBITDA was $0.363B, a 20.63% increase from 2022.
  • Medpace Holdings 2022 annual EBITDA was $0.301B, a 37% increase from 2021.
Medpace Holdings Annual EBITDA
(Millions of US $)
2024 $476
2023 $363
2022 $301
2021 $220
2020 $186
2019 $151
2018 $133
2017 $103
2016 $113
2015 $93
2014 $75
2013 $91
Medpace Holdings Quarterly EBITDA
(Millions of US $)
2025-03-31 $120
2024-12-31 $133
2024-09-30 $120
2024-06-30 $112
2024-03-31 $111
2023-12-31 $94
2023-09-30 $92
2023-06-30 $85
2023-03-31 $92
2022-12-31 $82
2022-09-30 $84
2022-06-30 $66
2022-03-31 $69
2021-12-31 $61
2021-09-30 $59
2021-06-30 $48
2021-03-31 $53
2020-12-31 $60
2020-09-30 $51
2020-06-30 $35
2020-03-31 $40
2019-12-31 $41
2019-09-30 $35
2019-06-30 $41
2019-03-31 $34
2018-12-31 $40
2018-09-30 $30
2018-06-30 $33
2018-03-31 $30
2017-12-31 $18
2017-09-30 $29
2017-06-30 $28
2017-03-31 $28
2016-12-31 $28
2016-09-30 $28
2016-06-30 $29
2016-03-31 $28
2015-12-31
2015-09-30 $7
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $9.228B $2.109B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.921B 26.99
Elevance Health (ELV) United States $89.416B 11.54
CVS Health (CVS) United States $88.020B 10.94
Cencora (COR) United States $57.242B 19.91
DiDi Global (DIDIY) China $22.544B 23.95
Labcorp Holdings (LH) United States $22.119B 17.94
Natera (NTRA) United States $21.946B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.094B 0.00
Solventum (SOLV) United States $13.476B 14.27
CochLear (CHEOY) Australia $12.827B 0.00
ICON (ICLR) Ireland $12.023B 11.18
Revvity (RVTY) United States $11.673B 20.09
Viatris (VTRS) United States $10.774B 3.70
Avantor (AVTR) United States $9.486B 13.78
HealthEquity (HQY) United States $8.897B 38.97
Sonic Healthcare (SKHHY) Australia $8.498B 0.00
Charles River Laboratories (CRL) United States $7.583B 14.86
Caris Life Sciences,�Inc (CAI) $6.744B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.758B 28.02
BrightSpring Health Services (BTSG) United States $3.915B 35.92
Sotera Health (SHC) United States $3.250B 18.47
Surgery Partners (SGRY) United States $2.890B 37.58
Alignment Healthcare (ALHC) United States $2.811B 0.00
Concentras Parent (CON) United States $2.671B 15.44
Organon (OGN) United States $2.613B 2.78
GeneDx Holdings (WGS) United States $2.576B 99.22
PACS (PACS) United States $1.974B 0.00
Ardent Health (ARDT) United States $1.964B 8.37
Progyny (PGNY) United States $1.891B 41.62
Premier (PINC) United States $1.789B 13.58
GoodRx Holdings (GDRX) United States $1.772B 35.43
Teladoc Health (TDOC) United States $1.505B 0.00
Establishment Labs Holdings (ESTA) $1.255B 0.00
Pediatrix Medical (MD) United States $1.231B 9.37
CareDx (CDNA) United States $1.050B 16.39
Agilon Health (AGL) United States $0.985B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.919B 0.00
AMN Healthcare Services Inc (AMN) United States $0.842B 7.88
QDM (QDMI) Hong Kong, SAR China $0.776B 0.00
Nutex Health (NUTX) United States $0.732B 11.09
Embecta (EMBC) United States $0.600B 4.04
LifeMD (LFMD) United States $0.597B 0.00
InnovAge Holding (INNV) United States $0.533B 0.00
SBC Medicals (SBC) United States $0.483B 0.00
Omada Health (OMDA) $0.470B 0.00
Auna S.A (AUNA) Luxembourg $0.466B 10.48
Sonida Senior Living (SNDA) United States $0.456B 0.00
Enhabit (EHAB) United States $0.399B 32.83
Performant Healthcare (PHLT) United States $0.322B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.296B 0.00
So-Young (SY) China $0.288B 0.00
Beauty Health (SKIN) United States $0.272B 0.00
Oncology Institute (TOI) United States $0.196B 0.00
DocGo (DCGO) United States $0.155B 25.33
Pheton Holdings (PTHL) China $0.121B 0.00
Sera Prognostics (SERA) United States $0.098B 0.00
KindlyMD (NAKA) United States $0.082B 0.00
Ascend Wellness Holdings (AAWH) United States $0.066B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
ModivCare (MODV) United States $0.045B 0.00
Biodesix (BDSX) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Basel Medical Group (BMGL) Singapore $0.030B 0.00
OSR Holdings (OSRH) United States $0.029B 0.00
BioNexus Gene Lab (BGLC) $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00